GC Genome Corporation (KOSDAQ:340450)
8,000.00
+380.00 (4.99%)
Nov 18, 2026, 3:30 PM KST
| Market Cap | 189.21B +14.8% |
| Revenue (ttm) | 32.64B +13.7% |
| Net Income | 5.42B +41,017.6% |
| EPS | 229.79 +33,695.5% |
| Shares Out | 23.65M |
| PE Ratio | 34.81 |
| Forward PE | 33.28 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 281,188 |
| Open | 7,920.00 |
| Previous Close | 7,620.00 |
| Day's Range | 7,620.00 - 8,590.00 |
| 52-Week Range | 4,100.00 - 10,480.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |